573 related articles for article (PubMed ID: 20551651)
1. Pancreatobiliary disorders associated with pancreaticobiliary maljunction.
Kamisawa T; Honda G; Kurata M; Tokura M; Tsuruta K
Dig Surg; 2010; 27(2):100-4. PubMed ID: 20551651
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in pancreaticobiliary maljunction.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Nobukawa B; Suda K
J Hepatobiliary Pancreat Surg; 2002; 9(1):45-54. PubMed ID: 12021897
[TBL] [Abstract][Full Text] [Related]
3. Pancreas divisum in pancreaticobiliary maljunction.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Matsukawa M
Hepatogastroenterology; 2008; 55(81):249-53. PubMed ID: 18507118
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of treatment for pancreaticobiliary maljunction without bile duct dilatation.
Ohuchida J; Chijiiwa K; Hiyoshi M; Kobayashi K; Konomi H; Tanaka M
Arch Surg; 2006 Nov; 141(11):1066-70. PubMed ID: 17116798
[TBL] [Abstract][Full Text] [Related]
5. Preferable operative age of choledochal dilation types to prevent patients with pancreaticobiliary maljunction from developing biliary tract carcinogenesis.
Kobayashi S; Ohnuma N; Yoshida H; Ohtsuka Y; Terui K; Asano T; Ryu M; Ochiai T
Surgery; 2006 Jan; 139(1):33-8. PubMed ID: 16364715
[TBL] [Abstract][Full Text] [Related]
6. Pancreatitis associated with pancreaticobiliary maljunction.
Kamisawa T; Matsukawa M; Amemiya K; Tu Y; Egawa N; Okamoto A; Aizawa S
Hepatogastroenterology; 2003; 50(53):1665-8. PubMed ID: 14571812
[TBL] [Abstract][Full Text] [Related]
7. Biliary carcinogenesis in pancreaticobiliary maljunction.
Kamisawa T; Kuruma S; Chiba K; Tabata T; Koizumi S; Kikuyama M
J Gastroenterol; 2017 Feb; 52(2):158-163. PubMed ID: 27704265
[TBL] [Abstract][Full Text] [Related]
8. Biliary carcinoma risk in patients with pancreaticobiliary maljunction and the degree of extrahepatic bile duct dilatation.
Kamisawa T; Tu Y; Kuwata G; Egawa N; Nakajima H; Tsuruta K; Okamoto A; Matsukawa M
Hepatogastroenterology; 2006; 53(72):816-8. PubMed ID: 17153430
[TBL] [Abstract][Full Text] [Related]
9. Dorsal pancreatic duct dominance in pancreaticobiliary maljunction.
Kamisawa T; Egawa N; Nakajima H; Matsukawa M
Pancreas; 2005 Apr; 30(3):e60-3. PubMed ID: 15782090
[TBL] [Abstract][Full Text] [Related]
10. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
11. Clinical abnormalities in adults with pancreaticobiliary maljunction with and without bile-duct dilatation.
Tanaka K; Nishimura A; Ishibe R; Yoshimine M; Ogata S; Taira A
Can J Surg; 1995 Aug; 38(4):351-4. PubMed ID: 7634202
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter bilis colonization of the biliary system in patients with pancreaticobiliary maljunction.
Kosaka T; Tajima Y; Kuroki T; Mishima T; Adachi T; Tsuneoka N; Fukuda K; Kanematsu T
Br J Surg; 2010 Apr; 97(4):544-9. PubMed ID: 20155791
[TBL] [Abstract][Full Text] [Related]
13. Sex-based differences in gallbladder cancer associated with pancreaticobiliary maljunction.
Kamisawa T; Munakata W; Tu Y; Egawa N; Tsuruta K; Okamoto A
Hepatogastroenterology; 2008; 55(81):21-3. PubMed ID: 18507071
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathology of pancreaticobiliary maljunction: relationship between alterations in background biliary epithelium and neoplastic development.
Seki M; Yanagisawa A; Ninomiya E; Ninomiya Y; Ohta H; Saiura A; Yamamoto J; Yamaguchi T; Aruga A; Yamada K; Takano K; Fujita R; Ikeda M; Sasaki K; Kato Y
J Hepatobiliary Pancreat Surg; 2005; 12(3):254-62. PubMed ID: 15995816
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
16. Recent advances and problems in the management of pancreaticobiliary maljunction: feedback from the guidelines committee.
Kamisawa T; Ando H; Shimada M; Hamada Y; Itoi T; Takayashiki T; Miyazaki M
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):87-92. PubMed ID: 23798483
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the accessory pancreatic duct.
Kamisawa T; Egawa N; Nakajima H; Sakaki N; Tsuruta K; Okamoto A
Hepatogastroenterology; 2003; 50(54):2196-8. PubMed ID: 14696497
[TBL] [Abstract][Full Text] [Related]
18. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.
Funabiki T; Matsubara T; Miyakawa S; Ishihara S
Langenbecks Arch Surg; 2009 Jan; 394(1):159-69. PubMed ID: 18500533
[TBL] [Abstract][Full Text] [Related]
19. Pancreaticobiliary maljunction and biliary cancer.
Kamisawa T; Kuruma S; Tabata T; Chiba K; Iwasaki S; Koizumi S; Kurata M; Honda G; Itoi T
J Gastroenterol; 2015 Mar; 50(3):273-9. PubMed ID: 25404143
[TBL] [Abstract][Full Text] [Related]
20. Pancreaticobiliary maljunction.
Kamisawa T; Takuma K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K; Sasaki T
Clin Gastroenterol Hepatol; 2009 Nov; 7(11 Suppl):S84-8. PubMed ID: 19896105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
